Raigulus

event

Broken Dawn Antiviral Race

The Broken Dawn pursuit of a broad-spectrum antiviral, with April Kelleher and Division Agents following a research lead into the American Midwest.

Connectionnot applicable Continuitydivision transmedia Canon scopeofficial transmedia Verificationsource reviewed Reviewed2026-10-12

A possible antiviral, not a finished cure

Broken Dawn's published premise centers on a potential broad-spectrum antiviral. The archive records that as a source-specific research lead and does not promote it into a confirmed cure for the wider franchise. [1][2][3]

The research lead

The reviewed sources describe a Midwest lead, a possible antiviral and a new threat, but they do not name the city, the organization or any transfer of information and samples. That sequence therefore stays open here rather than being reconstructed from the parts the sources do establish. [3]

Claim ledger

Every factual statement below must retain at least one traceable source.

  1. confirmed

    Ubisoft's published premise identifies a possible broad-spectrum antiviral as the research lead at the center of Broken Dawn's Midwest journey. [1][2]

  2. unknown

    The reviewed sources describe a Midwest lead, an antiviral possibility and a new threat, but do not name Ann Arbor, Washington or a transfer of information and samples; this archive does not confirm that sequence. [3]

  3. editorial distinction

    Broken Dawn's potential antiviral is a novel-specific research lead; its existence is not presented here as proof of a completed, franchise-wide cure. [1][3]

Related records

Sources

  1. [1] The Division: Broken Dawn Novel Explores Effects of Global Collapse. Ubisoft News (2019-03-26). Accessed 2026-07-28.
  2. [2] Find Out More About The Division With The Books Of The Game. Ubisoft (2019-01-09). Accessed 2026-07-28.
  3. [3] Tom Clancy's The Division: Broken Dawn. Penguin Random House Library Marketing (2019-03-26). Accessed 2026-07-28.

Comments